Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug development decisions.

• Jul 11, 2019
  

  A new talent joined our experienced team! We're excited to announce that Qing Xi, working more recently at the University of Otago, New Zealand, started at Pharmetheus.

• Jun 11, 2019
  Pharmetheus is at PAGE 2019 in Stockholm! We look forward to seeing you at booth no. 19-20.

• May 29, 2019
  A warm welcome to Robin Svensson, joining our MIDD consultants team! Robin recently graduated from Uppsala University with an important thesis work on how pharmacometrics can be used to improve decision-making for development and use of drugs against tuberculosis.

• May 22, 2019
  

  Pharmetheus is very happy to announce the addition of two new consultants to our growing team. Enrica Mezzalana joins us from Exprimo. Enrica has a PhD in Bioengineering and Bioinformatics and has been working for >5years as a pharmacometrician to support model informed drug development both in industry and in consultancy. She has experience in planning and conducting populationPK/PD analyses across different therapeutic areas as well as in building physiologically based models, applied primarily to DDI predictions. Tobias Kanacher also joins us from Exprimo. Tobias was formerly a consultant and Systems Pharmacology Expert at SGS Exprimo and Bayer. In that role he advised preclinical and clinical drug development teams how to apply PBPK modelling across different stages of clinical drug development. He contributed to the filing of new drug applications and has experience with regulatory interactions. Welcome to you both.

• Mar 8, 2019
  Pharmetheus possesses a blend of expertise to enhance model informed drug development (MIDD) at the trial, compound and/or organization level. We are able to offer a range of MIDD related services tailored to your needs, such as: Presentations focused on MIDD awareness Workshops focused on MIDD implementation Workshops focused on MIDD application within particular therapeutic areas Scientific advice at the analysis, trial and compound levels Delivery of a range of MIDD components in a “fit for purpose” manner   For more information please contact Marie Sandström and info@pharmetheus.com.

• Mar 8, 2019
  Pharmetheus is delighted to announce the appointment of Richard J Anziano as Chief Statistician. Rich was formerly Global Head of Statistics and Chief Statistician for Pfizer Inc. with responsibility for approximately 250 statisticians. In that role he led the quantitative assessment of late stage probabilities of technical and regulatory success through modeling and simulation for late-stage assets compared to industry/therapeutic area benchmarks. He was a long standing member of the cross PhRMA statistics group. He has over 25 years of drug development experience in Neuroscience, Pain, Cardiovascular, Infectious Disease, Rare Disease. He fostered a culture of collaboration and partnership across statisticians, clinical pharmacologists, and clinicians which enabled MIDD within Pfizer to effectively and efficiently support and inform development program strategies and decisions.

• Mar 7, 2019
  We’ve moved! Pharmetheus has moved its main premises to a larger office complex based in the Uppsala Science Park. Beyond Uppsala, our physical presence stretches out through our office network (currently Stockholm and Basel), and home office network (currently Germany, Italy, The Netherlands, UK, USA, Sweden)

• Feb 10, 2019
  Pharmetheus is pleased to announce the appointment of two new board members to our Board of Directors. Joining the Board are accomplished industry leaders Agneta Franksson and Fredrik Alpsten. Following the company’s recent growth and development, a reorganisation of the board was agreed to be in order. The new Board consists of Chairman Mats Karlsson, Martin Bergstrand, Elodie Plan, Agneta Franksson and Fredrik Alpsten.

• Feb 4, 2019
  We are very pleased to announce the arrival of three new team members. We welcome Moustafa Ibrahim, Consultant; Georges Etté, Data Programmer; and Eric Sandström, Data Programmer to our growing Pharmetheus team. Moustafa has recently completed his PhD in pharmacometrics from Uppsala University, under the supervision of Professor Mats Karlsson and Associate Professor Maria Kjellsson. Georges is an experienced statistician and programmer who joins us from Novartis, and Eric has just concluded a Master thesis project over the last 4 months with us at Pharmetheus. Welcome and good luck to you all!

• Jan 16, 2019
  The Pharmetheus team continues to grow. We would like to extend a warm welcome to three new employees who joined in January 2019. The three colleagues, Elin Matsson, Senior Consultant; Jurgen Langenhorst, Consultant and Peteris Prusis, Data Programmer add both extra capacity and additional capabilities to our high performing team. For more details on these colleagues, and the Pharmetheus Team as a whole please see our website which is about to undergo a revamp and refresh for 2019. Please inform us if there are elements you would like to see us add to the new website.